I've been looking at the per-patient costs of ESRD:

I'm seeing not only are companies like DaVita and Fresenius not keeping up with other countries - see Italy at top of
flyer - but they aren't keeping up with the non-profits here:

So I have to ask where is the money going? To me, this looks like a job for those Navy Seals of accounting, the Congressional Budget Office. To trim the fat, would be nice to know who is porking out.